Mankind Pharma Ltd
Healthcare
Flashback 2024: Top healthcare deals of the year
Dealmaking activity in India’s healthcare sector remained strong this year with several foreign private equity firms as well as local ......
General
Flashback 2024: Check out the top M&As of the year
The merger and acquisition (M&A) activity in India strengthened during 2024 compared with last year, with technology, media and telecom ......
Healthcare
ChrysCapital, LP co-investors set stage for nearly $800-mn exit
ChrysCapital, which hit the milestone of raising the largest-ever sector-agnostic private equity fund focused on India last year and has ......
Healthcare
IT Dept conducts searches at PE-backed Mankind Pharma a day after listing
The income tax department is conducting searches at Mankind Pharma Ltd's office in New Delhi, two government sources told Reuters ......
Healthcare
Mankind Pharma valuation nears $7 bn as shares jump on listing
Shares of India's Mankind Pharma Ltd ended with gains of 31.7% in their trading debut on Tuesday, valuing the maker ......
Finance
The year of caution for anchor investors after a bloody 2021
Primary markets are poised to cool further this year as anchor investors who burnt their fingers in new-age technology IPOs ......
General
Grapevine: Byju's rakes in $700 mn at flat valuation; Megha Engineering concludes Lanco Anpara deal
Edtech major Byju’s has raised $700 million at a flat valuation of $22 billion, involving two separate deals of equity ......
Healthcare
Analysis: M&A deal value in healthcare and pharma hits record high in Jan-June
Merger and acquisitions (M&As) deal value in the healthcare and pharmaceutical space hit a record high in Jan-June, crossing the ......
Healthcare
ChrysCapital set to reinvest in another pharmaceutical portfolio firm
Homegrown private equity firm ChrysCapital is in advanced talks to increase its stake in its oldest pharmaceutical portfolio company, which ......
Healthcare
PE deal of the month: ChrysCap backs Mankind in biggest-ever India healthcare bet
In an otherwise lean month of deal-making, domestic private equity major ChrysCapital’s decision to reinvest in Mankind Pharma, barely three ......